The Filings Report

McKesson Corporation

MCKNYSECIK 927653Healthcare / Healthcare Providers & Servicesfiscal year ends March73 quarters since 2008

Revenue, Q1 FY2027
$105.4B
+7.7% on Q1 FY2026
Net income
$614M
−21.7% on Q1 FY2026
Free cash flow
−$332M
+67.7% on Q1 FY2026
Diluted EPS
$5.15
−17.6% on Q1 FY2026
Revenue, TTM
$411.0B
trailing four quarters
Net margin, TTM
1.1%
net income $4.6B
Free cash flow, TTM
$6.4B
$6.9B less $437M capex
Cash and equivalents
$5.2B
long-term debt $9.7B, Jun 30, 2026
Shares, 12-month change
−6.3%
117M shares, Jun 30, 2026
Buybacks, TTM
$6.7B
5.8% of market value
Dividends, TTM
$393M
0.3% of market value
Market value
$116.0B
at the close, buybacks

Latest quarter Q1 FY2027, filed August 5, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q1 FY2027, the quarter ended June 30, 2026, McKesson Corporation reported revenue of $105.4B, +7.7% on Q1 FY2026, and net income of $614M (−21.7%). Operating margin was 1.3%. Free cash flow, operating cash flow less capital expenditures, was −$332M (−$220M less $112M). Diluted earnings per share were $5.15.

The last 16 quarters

Q2 FY2023 to Q1 FY2027, through the filing of August 5, 2026.

Revenue and net incomeRevenueNet income
$0$50B$100B$150BQ2'23, Revenue: $70.2BQ2'23, Net income: $926MQ2'23Q3'23, Revenue: $70.5BQ3'23, Net income: $1.1BQ3'23Q4'23, Revenue: $68.9BQ4'23, Net income: $787MQ4'23Q1'24, Revenue: $74.5BQ1'24, Net income: $958MQ1'24Q2'24, Revenue: $77.2BQ2'24, Net income: $664MQ2'24Q3'24, Revenue: $80.9BQ3'24, Net income: $589MQ3'24Q4'24, Revenue: $76.4BQ4'24, Net income: $791MQ4'24Q1'25, Revenue: $79.3BQ1'25, Net income: $915MQ1'25Q2'25, Revenue: $93.7BQ2'25, Net income: $241MQ2'25Q3'25, Revenue: $95.3BQ3'25, Net income: $879MQ3'25Q4'25, Revenue: $90.8BQ4'25, Net income: $1.3BQ4'25Q1'26, Revenue: $97.8BQ1'26, Net income: $784MQ1'26Q2'26, Revenue: $103.2BQ2'26, Net income: $1.1BQ2'26Q3'26, Revenue: $106.2BQ3'26, Net income: $1.2BQ3'26Q4'26, Revenue: $96.3BQ4'26, Net income: $1.7BQ4'26Q1'27, Revenue: $105.4BQ1'27, Net income: $614MQ1'27$0$50B$100B$150BQ2'23, Revenue: $70.2BQ2'23, Net income: $926MQ3'23, Revenue: $70.5BQ3'23, Net income: $1.1BQ3'23Q4'23, Revenue: $68.9BQ4'23, Net income: $787MQ1'24, Revenue: $74.5BQ1'24, Net income: $958MQ1'24Q2'24, Revenue: $77.2BQ2'24, Net income: $664MQ3'24, Revenue: $80.9BQ3'24, Net income: $589MQ3'24Q4'24, Revenue: $76.4BQ4'24, Net income: $791MQ1'25, Revenue: $79.3BQ1'25, Net income: $915MQ1'25Q2'25, Revenue: $93.7BQ2'25, Net income: $241MQ3'25, Revenue: $95.3BQ3'25, Net income: $879MQ3'25Q4'25, Revenue: $90.8BQ4'25, Net income: $1.3BQ1'26, Revenue: $97.8BQ1'26, Net income: $784MQ1'26Q2'26, Revenue: $103.2BQ2'26, Net income: $1.1BQ3'26, Revenue: $106.2BQ3'26, Net income: $1.2BQ3'26Q4'26, Revenue: $96.3BQ4'26, Net income: $1.7BQ1'27, Revenue: $105.4BQ1'27, Net income: $614MQ1'27

Net income losses drawn in red.

Free cash flow
−$5B$0$5B$10BQ2'23, Free cash flow: $1.0BQ2'23Q3'23, Free cash flow: $1.6BQ3'23Q4'23, Free cash flow: $3.2BQ4'23Q1'24, Free cash flow: −$1.1BQ1'24Q2'24, Free cash flow: $890MQ2'24Q3'24, Free cash flow: $164MQ3'24Q4'24, Free cash flow: $4.0BQ4'24Q1'25, Free cash flow: −$1.5BQ1'25Q2'25, Free cash flow: $2.0BQ2'25Q3'25, Free cash flow: −$2.5BQ3'25Q4'25, Free cash flow: $7.6BQ4'25Q1'26, Free cash flow: −$1.0BQ1'26Q2'26, Free cash flow: $2.3BQ2'26Q3'26, Free cash flow: $1.1BQ3'26Q4'26, Free cash flow: $3.3BQ4'26Q1'27, Free cash flow: −$332MQ1'27−$5B$0$5B$10BQ2'23, Free cash flow: $1.0BQ3'23, Free cash flow: $1.6BQ3'23Q4'23, Free cash flow: $3.2BQ1'24, Free cash flow: −$1.1BQ1'24Q2'24, Free cash flow: $890MQ3'24, Free cash flow: $164MQ3'24Q4'24, Free cash flow: $4.0BQ1'25, Free cash flow: −$1.5BQ1'25Q2'25, Free cash flow: $2.0BQ3'25, Free cash flow: −$2.5BQ3'25Q4'25, Free cash flow: $7.6BQ1'26, Free cash flow: −$1.0BQ1'26Q2'26, Free cash flow: $2.3BQ3'26, Free cash flow: $1.1BQ3'26Q4'26, Free cash flow: $3.3BQ1'27, Free cash flow: −$332MQ1'27

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$3B$5B$8B$10BQ2'23, Cash and equivalents: $2.9BQ2'23Q3'23, Cash and equivalents: $2.8BQ3'23Q4'23, Cash and equivalents: $4.7BQ4'23, Long-term debt: $5.6BQ4'23Q1'24, Cash and equivalents: $2.6BQ1'24, Long-term debt: $5.7BQ1'24Q2'24, Cash and equivalents: $2.5BQ2'24, Long-term debt: $5.6BQ2'24Q3'24, Cash and equivalents: $2.0BQ3'24, Long-term debt: $5.7BQ3'24Q4'24, Cash and equivalents: $4.6BQ4'24, Long-term debt: $5.6BQ4'24Q1'25, Cash and equivalents: $2.3BQ1'25, Long-term debt: $5.6BQ1'25Q2'25, Cash and equivalents: $2.5BQ2'25, Long-term debt: $5.7BQ2'25Q3'25, Cash and equivalents: $1.1BQ3'25, Long-term debt: $5.6BQ3'25Q4'25, Cash and equivalents: $5.7BQ4'25, Long-term debt: $5.7BQ4'25Q1'26, Cash and equivalents: $2.4BQ1'26, Long-term debt: $7.8BQ1'26Q2'26, Cash and equivalents: $4.0BQ2'26, Long-term debt: $7.8BQ2'26Q3'26, Cash and equivalents: $3.0BQ3'26, Long-term debt: $6.6BQ3'26Q4'26, Cash and equivalents: $4.0BQ4'26, Long-term debt: $6.5BQ4'26Q1'27, Cash and equivalents: $5.2BQ1'27, Long-term debt: $9.7BQ1'27$0$3B$5B$8B$10BQ2'23, Cash and equivalents: $2.9BQ3'23, Cash and equivalents: $2.8BQ3'23Q4'23, Cash and equivalents: $4.7BQ4'23, Long-term debt: $5.6BQ1'24, Cash and equivalents: $2.6BQ1'24, Long-term debt: $5.7BQ1'24Q2'24, Cash and equivalents: $2.5BQ2'24, Long-term debt: $5.6BQ3'24, Cash and equivalents: $2.0BQ3'24, Long-term debt: $5.7BQ3'24Q4'24, Cash and equivalents: $4.6BQ4'24, Long-term debt: $5.6BQ1'25, Cash and equivalents: $2.3BQ1'25, Long-term debt: $5.6BQ1'25Q2'25, Cash and equivalents: $2.5BQ2'25, Long-term debt: $5.7BQ3'25, Cash and equivalents: $1.1BQ3'25, Long-term debt: $5.6BQ3'25Q4'25, Cash and equivalents: $5.7BQ4'25, Long-term debt: $5.7BQ1'26, Cash and equivalents: $2.4BQ1'26, Long-term debt: $7.8BQ1'26Q2'26, Cash and equivalents: $4.0BQ2'26, Long-term debt: $7.8BQ3'26, Cash and equivalents: $3.0BQ3'26, Long-term debt: $6.6BQ3'26Q4'26, Cash and equivalents: $4.0BQ4'26, Long-term debt: $6.5BQ1'27, Cash and equivalents: $5.2BQ1'27, Long-term debt: $9.7BQ1'27

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q1 FY2027 filed August 5, 2026.

McKesson Corporation income statement, quarterly
Millions of dollarsQ1 FY2027ended Jun 30, 2026filed Aug 5, 2026Q4 FY2026ended Mar 31, 2026filed May 8, 2026Q3 FY2026ended Dec 31, 2025filed Feb 4, 2026Q2 FY2026ended Sep 30, 2025filed Nov 6, 2025Q1 FY2026ended Jun 30, 2025filed Aug 6, 2025Q4 FY2025ended Mar 31, 2025filed May 9, 2025Q3 FY2025ended Dec 31, 2024filed Feb 6, 2025Q2 FY2025ended Sep 30, 2024filed Nov 7, 2024YoYQ1 FY2027vs Q1 FY2026
Revenue105,38096,295106,158103,15097,82790,82395,29493,651+7.7%
Cost of revenue101,69592,251102,47399,60894,54887,18492,01090,403+7.6%
Gross profit3,6854,0443,6853,5423,2793,6393,2843,248+12.4%
Research and development—————————
Selling, general and administrative2,2641,7962,0302,0742,1961,9752,0282,503+3.1%
Operating income1,3192,1501,6191,4071,0361,5911,224578+27.3%
Other income (expense)6636746264(31)6934+3.1%
Pretax income1,3082,1251,6301,3951,0511,5151,226534+24.5%
Income tax276270380232220209298247+25.5%
Net income6141,6821,1861,1107841,260879241−21.7%
Diluted EPS ($)5.15—9.598.926.25—6.951.87−17.6%
Diluted shares (millions)119—124124126—127129—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q1 FY2027 filed August 5, 2026.

McKesson Corporation balance sheet, quarterly
Millions of dollarsQ1 FY2027ended Jun 30, 2026filed Aug 5, 2026Q4 FY2026ended Mar 31, 2026filed May 8, 2026Q3 FY2026ended Dec 31, 2025filed Feb 4, 2026Q2 FY2026ended Sep 30, 2025filed Nov 6, 2025Q1 FY2026ended Jun 30, 2025filed Aug 6, 2025Q4 FY2025ended Mar 31, 2025filed May 9, 2025Q3 FY2025ended Dec 31, 2024filed Feb 6, 2025Q2 FY2025ended Sep 30, 2024filed Nov 7, 2024YoYQ1 FY2027vs Q1 FY2026
Cash and equivalents5,1643,9752,9594,0042,4185,6911,1312,509+113.6%
Short-term investments—————————
Total current assets62,83757,21059,69759,88756,80155,39851,74153,341+10.6%
Total assets88,33082,32384,19084,16081,31175,14071,08172,429+8.6%
Total current liabilities70,35667,01768,13168,03164,33161,60458,56258,771+9.4%
Long-term debt9,7296,5266,5577,7587,7775,6545,5875,744+25.1%
Total liabilities—————————
Stockholders’ equity(4,240)(2,172)(1,298)(1,739)(1,967)(2,074)(3,084)(3,017)−115.6%
Shares outstanding (millions)117120122123124125125127—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q1 FY2027 filed August 5, 2026.

McKesson Corporation cash flow statement, quarterly
Millions of dollarsQ1 FY2027ended Jun 30, 2026filed Aug 5, 2026Q4 FY2026ended Mar 31, 2026filed May 8, 2026Q3 FY2026ended Dec 31, 2025filed Feb 4, 2026Q2 FY2026ended Sep 30, 2025filed Nov 6, 2025Q1 FY2026ended Jun 30, 2025filed Aug 6, 2025Q4 FY2025ended Mar 31, 2025filed May 9, 2025Q3 FY2025ended Dec 31, 2024filed Feb 6, 2025Q2 FY2025ended Sep 30, 2024filed Nov 7, 2024YoYQ1 FY2027vs Q1 FY2026
Operating cash flow(220)3,4211,2322,420(918)7,748(2,383)2,100+76.0%
Capital expenditures112111108106111169126136+0.9%
Free cash flow (CFO − capex)(332)3,3101,1242,314(1,029)7,579(2,509)1,964+67.7%
Depreciation and amortization195(246)188188157(213)153163+24.2%
Share repurchases2,5302,6716808185813008271,492+335.5%
Dividends paid1021011018990919280+13.3%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2026 filed May 8, 2026.

Income statement

McKesson Corporation income statement, annual
Millions of dollarsFY2026ended Mar 31, 2026filed May 8, 2026FY2025ended Mar 31, 2025filed May 9, 2025FY2024ended Mar 31, 2024filed May 8, 2024FY2023ended Mar 31, 2023filed May 9, 2023FY2022ended Mar 31, 2022filed May 9, 2022FY2021ended Mar 31, 2021filed May 12, 2021FY2020ended Mar 31, 2020filed May 22, 2020FY2019ended Mar 31, 2019filed May 15, 2019FY2018ended Mar 31, 2018filed May 24, 2018FY2017ended Mar 31, 2017filed May 22, 2017FY2016ended Mar 31, 2016filed May 5, 2016FY2015ended Mar 31, 2015filed May 12, 2015FY2014ended Mar 31, 2014filed May 14, 2014FY2013ended Mar 31, 2013filed May 7, 2013FY2012ended Mar 31, 2012filed May 2, 2012FY2011ended Mar 31, 2011filed May 5, 2011FY2010ended Mar 31, 2010filed May 4, 2010FY2009ended Mar 31, 2009filed Jul 28, 2009FY2008ended Mar 31, 2008filed Jul 28, 2009
Revenue403,430359,051308,951276,711263,966238,228231,051214,319208,357198,533190,884179,045137,392122,196122,321112,084108,702106,632101,703
Cost of revenue388,880345,728296,123264,353250,836226,080219,028202,565197,173187,262179,468167,634129,040115,315115,919106,114103,026101,25496,694
Gross profit14,55013,32312,82812,35813,13012,14812,02311,75411,18411,27111,41611,4118,3526,8816,4025,9705,6765,3785,009
Research and development——————9671125341392392457433402407376364347
Selling, general and administrative8,0968,5078,6577,77610,5378,8499,1828,4378,1387,4477,3797,9015,3884,1103,7271,8421,6841,6391,559
Operating income6,2124,4223,9094,3812,038(5,040)2,4898867627,1223,5452,9682,4392,3472,1241,8212,0081,1961,478
Other income (expense)23620213249725922312182130775863323420364312121
Pretax income6,2014,3593,7894,6301,928(5,034)1,1446102396,8913,2502,6572,1711,9501,8931,6351,8641,064—
Income tax1,102878629905636(695)18356(53)1,614908815757587514505601241468
Net income4,7623,2953,0023,5601,114(4,539)90034675,0702,2581,4761,2631,3381,4031,2021,263823—
Diluted EPS ($)38.3825.7222.3925.037.23(28.26)4.950.170.3222.739.706.275.415.595.594.574.622.953.32
Diluted shares (millions)124128134142154161182197209223233235233239251263273279298

Balance sheet

McKesson Corporation balance sheet, annual
Millions of dollarsFY2026ended Mar 31, 2026filed May 8, 2026FY2025ended Mar 31, 2025filed May 9, 2025FY2024ended Mar 31, 2024filed May 8, 2024FY2023ended Mar 31, 2023filed May 9, 2023FY2022ended Mar 31, 2022filed May 9, 2022FY2021ended Mar 31, 2021filed May 12, 2021FY2020ended Mar 31, 2020filed May 22, 2020FY2019ended Mar 31, 2019filed May 15, 2019FY2018ended Mar 31, 2018filed May 24, 2018FY2017ended Mar 31, 2017filed May 22, 2017FY2016ended Mar 31, 2016filed May 5, 2016FY2015ended Mar 31, 2015filed May 12, 2015FY2014ended Mar 31, 2014filed May 14, 2014FY2013ended Mar 31, 2013filed May 7, 2013FY2012ended Mar 31, 2012filed May 2, 2012FY2011ended Mar 31, 2011filed May 5, 2011FY2010ended Mar 31, 2010filed May 4, 2010FY2009ended Mar 31, 2009filed Jul 28, 2009FY2008ended Mar 31, 2008filed Jul 28, 2009
Cash and equivalents3,9755,6914,5834,6783,5326,2784,0152,9812,6722,7834,0485,3414,1932,4563,1493,6123,7312,1091,362
Short-term investments———————————————————
Total current assets57,21055,39847,97044,29246,23145,38242,22238,46537,13636,94838,43536,67032,83623,17023,60322,35721,50418,671—
Total assets82,32375,14067,44362,32063,29865,01561,24759,67260,38160,96956,52353,87051,75934,78633,09330,88628,18925,267—
Total current liabilities67,01761,60452,35747,95748,46644,10342,62437,62636,68535,61235,06933,49729,61521,35721,68618,72617,01215,606—
Long-term debt6,5265,6545,6295,5945,8797,1487,3877,5957,8808,3628,1079,70910,3464,8733,5803,5872,2932,290—
Total liabilities———————————————————
Stockholders’ equity(2,172)(2,074)(1,971)(1,857)(2,272)(21)5,0928,0949,80411,0958,9248,0018,5227,0706,8317,2207,5326,193—
Shares outstanding (millions)120125130136145158162190202211225232231227235252271266—

Cash flow statement

McKesson Corporation cash flow statement, annual
Millions of dollarsFY2026ended Mar 31, 2026filed May 8, 2026FY2025ended Mar 31, 2025filed May 9, 2025FY2024ended Mar 31, 2024filed May 8, 2024FY2023ended Mar 31, 2023filed May 9, 2023FY2022ended Mar 31, 2022filed May 9, 2022FY2021ended Mar 31, 2021filed May 12, 2021FY2020ended Mar 31, 2020filed May 22, 2020FY2019ended Mar 31, 2019filed May 15, 2019FY2018ended Mar 31, 2018filed May 24, 2018FY2017ended Mar 31, 2017filed May 22, 2017FY2016ended Mar 31, 2016filed May 5, 2016FY2015ended Mar 31, 2015filed May 12, 2015FY2014ended Mar 31, 2014filed May 14, 2014FY2013ended Mar 31, 2013filed May 7, 2013FY2012ended Mar 31, 2012filed May 2, 2012FY2011ended Mar 31, 2011filed May 5, 2011FY2010ended Mar 31, 2010filed May 4, 2010FY2009ended Mar 31, 2009filed Jul 28, 2009FY2008ended Mar 31, 2008filed Jul 28, 2009
Operating cash flow6,1556,0854,3145,1594,4344,5424,3744,0364,3454,7443,6723,1123,1362,4832,9502,3382,3161,351869
Capital expenditures436537431390388451362426405404488376278241221233199195195
Free cash flow (CFO − capex)5,7195,5483,8834,7694,0464,0914,0123,6103,9404,3403,1842,7362,8582,2422,7292,1052,1171,156674
Depreciation and amortization2872722792723123443353179519108851,017735581493496477313—
Share repurchases4,7503,1463,0253,6383,5167421,9341,6391,7092,3111,6124501301,2141,8742,050323——
Dividends paid38134531429227727629429226225324422721419419517113111670

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$1M
3 sales by 3 insiders; officers and directors $1M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$29M
19 sales by 8 insiders; officers and directors $29M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 15, 2026Fraga FranciscoEVP, CIO and CTOopen-market sale10b5-1800$995.80$797K5,423Oct 19, 2026
Sep 8, 2026Rutledge Napoleon B JRSVP, Controller & CAOopen-market sale10b5-1111$891.45$99K521Sep 10, 2026
Aug 10, 2026Lerman Bradley EDirectoropen-market sale301$892.33$269K0Aug 11, 2026
Jul 22, 2026Wilson-Thompson KathleenDirectoraward277$814.04$225K578Jul 23, 2026
Jul 22, 2026Caruso Dominic JDirectoraward277$814.04$225K927Jul 23, 2026
Jul 22, 2026Martinez MariaDirectoraward277$814.04$225K578Jul 23, 2026
Jul 7, 2026Tyler Brian S.Chief Executive Officer, Directoropen-market sale10b5-18,463$793.56$7M5,919Jul 8, 2026
Jun 17, 2026Tyler Brian S.Chief Executive Officer, Directoropen-market sale10b5-18,463$775.13$7M14,382Jun 18, 2026
Jun 9, 2026Tyler Brian S.Chief Executive Officer, Directoropen-market sale10b5-14,929$763.00$4M22,845Jun 11, 2026
Jun 5, 2026Rutledge Napoleon B JRSVP, Controller & CAOopen-market sale10b5-1133$764.00$102K632Jun 8, 2026
Jun 2, 2026Rodgers Thomas LEVP, Chief Strategy & BDOopen-market sale10b5-1699$735.27$514K2,268Jun 3, 2026
Jun 1, 2026Rodgers Thomas LEVP, Chief Strategy & BDOopen-market sale10b5-1123$735.50$90K2,967Jun 3, 2026
Jun 1, 2026Smith LeAnn BEVP & Chief HR Officeropen-market sale10b5-11,810$735.50$1M4,798Jun 2, 2026
May 26, 2026Lau MicheleEVP and Chief Legal Officeropen-market sale10b5-13,550$761.09$3M3,247May 27, 2026
May 26, 2026Rodgers Thomas LEVP, Chief Strategy & BDOopen-market sale10b5-12,388$761.09$2M3,090May 27, 2026
May 23, 2026Tyler Brian S.Chief Executive Officer, Directoroption exercise4,579$0.00—29,605May 27, 2026
May 23, 2026Tyler Brian S.Chief Executive Officer, Directortax withholding1,831$766.08$1M27,774May 27, 2026
May 23, 2026Vitalone Britt J.EVP & CFOoption exercise1,476$0.00—22,534May 27, 2026
May 23, 2026Vitalone Britt J.EVP & CFOtax withholding581$766.08$445K21,953May 27, 2026
May 23, 2026Smith LeAnn BEVP & Chief HR Officeroption exercise679$0.00—6,876May 27, 2026
May 23, 2026Smith LeAnn BEVP & Chief HR Officertax withholding268$766.08$205K6,608May 27, 2026
May 23, 2026Rodgers Thomas LEVP, Chief Strategy & BDOoption exercise594$0.00—5,712May 27, 2026
May 23, 2026Rodgers Thomas LEVP, Chief Strategy & BDOtax withholding234$766.08$179K5,478May 27, 2026
May 23, 2026Rutledge Napoleon B JRSVP, Controller & CAOoption exercise136$0.00—806May 27, 2026
May 23, 2026Rutledge Napoleon B JRSVP, Controller & CAOtax withholding41$766.08$31K765May 27, 2026

Full insider history for McKesson Corporation, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held MCK in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded MCK by quarter.

FundManagerQuarterValueSharesWeightMove
Lone Pine CapitalSteve MandelQ2 2026$44M57,8510.27%trimmed −85.3%

Sources

Fiscal year ends in month 3; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
McKESSON CORPORATION, CIK 927653 on EDGAR
Extract generated
August 27, 2026
Withheld
none
Repaired
4 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: other income FY2009, operating income FY2018, pretax income FY2018, pretax income FY2019
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, Revenues, SalesRevenueNet
Cost of revenue: CostOfGoodsAndServicesSold, CostOfRevenue
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: GeneralAndAdministrativeExpense, SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense, OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebt, LongTermDebtNoncurrent
Total liabilities: not filed
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization, DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends, PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated August 27, 2026.

JSON file
/data/financials/MCK.json